Biliary tract carcinoma, including carcinoma of the gallbladder, intrahepatic bile ducts (cholangiocarcinoma), and extrahepatic bile ducts, affects 7500 people in the United States annually, and has ...

We reviewed the histological sections from a consecutive series of eighty-one (81) esophago-gastrectomy cases received and reported at Sullivan Nicolaides Pathology between June 2001 and December 2006 ...

A phase I clinical trial of S-1 in combination with sorafenib for patients with advanced hepatocellular carcinoma. Background: p16INK4a is a cyclin-dependent kinase inhibitor, together with p21, p53 ...

SAN DIEGO, California — A survey of Western patients with intestinal metaplasia of the stomach (IMS) shows they are at an 11-fold risk for gastric carcinoma (GCA) and that the median time to ...

Quality indicator for esophagogastroduodenoscopy in screening gastric cancer. A prospective study of repeat endoscopic biopsy to identify HER2-positive tumors following an initial HER2-negative biopsy ...

A new study reports that endoluminal (endoscopic) therapies, combining resection and ablation techniques, for patients with Barrett's esophagus and high-grade dysplasia or early mucosal cancer have a ...

Please provide your email address to receive an email when new articles are posted on . Among patients with gastric intestinal metaplasia, the risk for dysplasia or early gastric cancer was increased ...

ORLANDO — Endoscopic therapy was equally effective in patients with Barrett’s esophagus who had intramucosal carcinoma or high-grade dysplasia, according to research presented at the World Congress of ...

Radiofrequency ablation is a safe and effective option for the treatment of dysplastic Barrett's esophagus that attains lasting response, new research suggests. Radiofrequency ablation (RFA) is a safe ...

Radiofrequency ablation is an effective treatment for dysplasia in people with Barrett's esophagus, a condition that can lead to deadly gastrointestinal cancer, according to a landmark clinical trial ...